Possible involvement of endothelial leukotriene in acetylcholine-induced contraction in rabbit coronary artery

Life Sciences

Volumn 59, Issue 12, 1996, Pages 961-967

  Jino, Hiroshi ^a   Kurahashi, Kazuyoshi ^a   Usui, Hachiro ^a   Nakata, Youhei ^a   Shimizu, Yoshiharu ^b  

^a KYOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Coronary artery; Endothelium dependent contraction; Leukotrienes

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; 2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ACETYLCHOLINE; ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIOXIDANT; ARGININE; CATALASE; DOMITROBAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MANOALIDE; N(G) NITROARGININE METHYL ESTER; PHOSPHOLIPASE A2 INHIBITOR; POBILUKAST; PRANLUKAST; PROSTAGLANDIN SYNTHASE INHIBITOR; SUPEROXIDE; SUPEROXIDE DISMUTASE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; DRUG ANTAGONISM; MALE; NONHUMAN; RABBIT; VASCULAR ENDOTHELIUM;

EID: 0030590224     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00402-X     Document Type: Article

References (22)

1. 1. R. F. FURCHGOTT and J. V. ZAWADZKI, Nature 288 373-376 (1980).
2. 2. R. M. J. PALMER, A. G. FERRIGE and S. MONCADA, Nature 327 524-526 (1987).
3. 3. H. USUI, K. KURAHASHI, K. ASHIDA and M. FUJIWARA, Med. Sci. Res. 11 418-419 (1983).
4. 4. H. USUI, M. FUJIWARA, T. TSUBOMURA, K. KURAHASHI, S. NOMURA and N. MIZUNO, Neural Regulation of Brain Circulation, C. Owman and J. E. Hardebo (Eds) 261-272, Elsevier Science Publishers, Amsterdam (1986).
5. 5. H. SHIRAHASE, H. USUI, K. KURAHASHI, M. FUJIWARA and K. FUKUI, J. Cardiovasc. Pharmacol. 10 517-522 (1987).
6. 6. J. L. AMEZCUA, R. M. J. PALMER, B. M. DE SOUZA and S. MONCADA, Br. J. Pharmacol. 97 1119-1124 (1989).
7. 7. R. G. HUMPHRIES, R. D. CARR, A. K. NICOL, W. TOMLINSON and S. E. O' CONNOR, Br. J. Pharmacol. 102 565-566 (1991).
8. 8. H. JINO, H. USUI, S. TEMMA, H. SHIRAHASE and K. KURAHASHI, Br. J. Pharmacol. 111 435 (1994).
9. 9. H. USUI, K. KURAHASHI, H. JINO, H. SHIRAHASE, S. TEMMA, S. NAKAMURA and Y. NAKATA, Japan. J. Pharmacol. 67 119P (1995).
10. 10. M. YANAGISAWA, H. KURIHARA, S. KIMURA, Y. TOMOBE, M. KOBAYASHI, Y. MITSUI, Y. YAZAKI, K. GOTO and T. MASAKI, Nature 332 411-415 (1988).
11. 11. Z. S. KATUSIC and P. M. VANHOUTTE, Am. J. Physiol. 257 H33-H37 (1989).
12. 12. K. B. GLASER and R. S. JACOBS, Biochem. Pharmacol. 35 449-453 (1985).
13. 13. C. NEBIGIL and K. U. MALIK, J. Pharmacol. Exp. Ther. 266 1113-1124 (1993).
14. 14. S. E. HALL, Med. Res. Rev. 11 503-579 (1991).
15. 15. I. GORENNE, C. LABAT, , J. P. GASCARD, X. NOREL, R. MULLER-PEDDINGHAUS, K. H. MOHRS, W. A. TAYLOR, P. J. GARDINER and C. BRINK, J. Pharmacol. Exp. Ther. 20 208-210 (1993).
16. 16. T. ITO, Y. TOKI, N. HIEDA, K. OKUMURA, H. HASHIMOTO, K. OGAWA and T. SATAKE, Japan. Circ. J. 53 1115-1121 (1989).
17. 17. S. MONG, H. L. WU. J. MILLER, R. F. HALL, J. G. GLEASON and S. T. CROOKE, Mol. Pharmacol. 32 223-229 (1987).
18. 18. X. C. W U, N. T. RICHARDS, J. MICHAEL and E. JOHNS, Br. J. Pharmacol. 112 369-376 (1994).
19. 19. J. KANNER, S. HAREL and R. GRANIT, Lipids 27 46-49 (1992).
20. 20. K. SOGABE, H. NIREI, M. SHOUBO, A. NOMOTO, S. AO, Y. NOTSU and T. ONO, J. Pharmacol. Exp. Ther. 264 1040-1046 (1992).
21. 21. J. F. SECCOMBE and H. V. SCHAFF, Ann. Thrac. Surg. 60 778-788 (1995).
22. 22. M. CARRY, V. KORLEY, J. T. WILLERSON, A. W. FORD-HUTCHINSON and P. TAGARI , Circulation 85 230-236 (1992).